Comparison of 4 commercially available group B Streptococcus molecular assays using remnant rectal-vaginal enrichment broths

The incidence of neonatal Group B streptococcal (GBS) disease has significantly declined since the widespread implementation of prenatal screening of expectant mothers for urogenital and gastrointestinal tract GBS colonization. Screening methods have evolved from exclusively culture-based approaches to more rapid and highly sensitive molecular methods. We chose to evaluate the performance of 4 commercially available GBS molecular tests for detection of GBS colonization using 299 antepartum rectal-vaginal specimens submitted to our laboratory for routine GBS screening. In 97% of instances, there was agreement between all 3 systems. When testing 1, 6, and 12 samples simultaneously, all methods performed comparably, but the ARIES (R) GBS assay required the least total hands-on time and the illumigene (R) Group B Streptococcus assay required the most hands-on time. (C) 2018 Elsevier Inc. All rights reserved.